Chronic Inflammation in Ulcerative Colitis Causes Long-Term Changes in Goblet Cell Function
暂无分享,去创建一个
M. Donowitz | Julie G. In | Jianyi Yin | Jennifer Foulke-Abel | N. Zachos | Varsha Singh | R. Lin | Huimin Yu | Y. Rong | Kelli F. Johnson | Sun Lee
[1] L. Arike,et al. An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function , 2021, Science.
[2] D. Rubin,et al. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission , 2020, Alimentary pharmacology & therapeutics.
[3] M. Donowitz,et al. Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during enterotoxigenic Escherichia coli infection , 2020, Gut microbes.
[4] R. Paulssen,et al. Transcriptional Signatures That Define Ulcerative Colitis in Remission , 2020, Inflammatory bowel diseases.
[5] J. Yamamoto-Furusho,et al. ABCC7/CFTR Expression is Down-regulated in Patients with Active Ulcerative Colitis , 2020 .
[6] N. Akhtar,et al. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis , 2019, Gut.
[7] A. Verkman,et al. cAMP Stimulates SLC26A3 Activity in Human Colon by a CFTR-Dependent Mechanism That Does Not Require CFTR Activity , 2018, bioRxiv.
[8] M. Donowitz,et al. Molecular Basis and Differentiation-Associated Alterations of Anion Secretion in Human Duodenal Enteroid Monolayers , 2018, Cellular and molecular gastroenterology and hepatology.
[9] M. Donowitz,et al. A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions , 2017, Scientific Reports.
[10] P. Jung,et al. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis , 2016, Gut.
[11] C. Serrano,et al. The pro-inflammatory cytokines IFNγ/TNFα increase chromogranin A-positive neuroendocrine cells in the colonic epithelium. , 2016, The Biochemical journal.
[12] M. Halushka,et al. Enterohemorrhagic Escherichia coli Reduces Mucus and Intermicrovillar Bridges in Human Stem Cell-Derived Colonoids , 2015, Cellular and molecular gastroenterology and hepatology.
[13] W. Xia,et al. Slc26a3 deficiency is associated with loss of colonic HCO3− secretion, absence of a firm mucus layer and barrier impairment in mice , 2014, Acta physiologica.
[14] Lilia Zouiten-Mekki,et al. [Epithelial cell in intestinal homeostasis and inflammatory bowel diseases]. , 2013, Medecine sciences : M/S.
[15] P. Quinton,et al. Normal mucus formation requires cAMP‐dependent HCO3− secretion and Ca2+‐mediated mucin exocytosis , 2013, The Journal of physiology.
[16] C. Abraham,et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. , 2013, Gastroenterology.
[17] A. Gewirtz,et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis , 2013, Gut.
[18] R. Wollman,et al. Coordinated oscillations in cortical actin and Ca2+ correlate with cycles of vesicle secretion , 2012, Nature Cell Biology.
[19] M. Parkes,et al. Mucosal genome‐wide methylation changes in inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[20] I. Ordás,et al. Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations , 2012, Gut.
[21] M. Johansson,et al. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. , 2012, Glycobiology.
[22] J. Wehkamp,et al. Inflammatory bowel disease: an impaired barrier disease , 2012, Langenbeck's Archives of Surgery.
[23] Hans Clevers,et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.
[24] P. Quinton,et al. A new role for bicarbonate in mucus formation. , 2010, American journal of physiology. Lung cellular and molecular physiology.
[25] O. Nielsen,et al. Genome‐wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis , 2010, Inflammatory bowel diseases.
[26] Linheng Li,et al. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. , 2010, Immunity.
[27] R. Sidhu,et al. Elevated serum chromogranin A in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): a shared model for pathogenesis? , 2010, Inflammatory bowel diseases.
[28] R. Lisle. Pass the bicarb: the importance of HCO3– for mucin release , 2009 .
[29] P. Quinton,et al. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. , 2009, The Journal of clinical investigation.
[30] G. Hansson,et al. A complex, but uniform O-glycosylation of the human MUC2 mucin from colonic biopsies analyzed by nanoLC/MSn. , 2009, Glycobiology.
[31] J. Marth,et al. Glycosyltransferase Function in Core 2-Type Protein O Glycosylation , 2009, Molecular and Cellular Biology.
[32] Guoxing Wang,et al. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis. , 2009, Differentiation; research in biological diversity.
[33] R. D. De Lisle. Pass the bicarb: the importance of HCO3- for mucin release. , 2009, The Journal of clinical investigation.
[34] Michael A. Hollingsworth,et al. Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.
[35] L. Abdullah,et al. Mucin secretion and PKC isoforms in SPOC1 goblet cells: differential activation by purinergic agonist and PMA. , 2003, American journal of physiology. Lung cellular and molecular physiology.
[36] J. Kere,et al. Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[37] W. Tremaine,et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.
[38] D. Evans,et al. Three Characteristics Associated with Enterotoxigenic Escherichia coli Isolated from Man , 1973, Infection and immunity.